Similar articles

• A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma.

  Mapp S, Sandhu G, Carrington C, Hennig S. Mapp S, et al. Leuk Lymphoma. 2016;57(4):981-4. doi: 10.3109/10428194.2015.1087520. Epub 2015 Oct 12. Leuk Lymphoma. 2016. PMID: 26325127 No abstract available.
• Otolaryngologic manifestations of acute leukemia and lymphoma.

  Fierstein JT, Thawley SE. Fierstein JT, et al. South Med J. 1978 Mar;71(3):277-80. doi: 10.1097/00007611-197803000-00023. South Med J. 1978. PMID: 628851
• Therapy of leukemia and lymphoma.

  Rigberg S, Kahn SB. Rigberg S, et al. Semin Drug Treat. 1973 Summer;3(1):73-85. Semin Drug Treat. 1973. PMID: 4715479 No abstract available.
• Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.

  Fox TA, Troy-Barnes E, Kirkwood AA, Chan WY, Day JW, Chavda SJ, Kumar EA, David K, Tomkins O, Sanchez E, Scully M, Khwaja A, Lambert J, Singer M, Roddie C, Morris EC, Yong KL, Thomson KJ, Ardeshna KM. Fox TA, et al. Br J Haematol. 2020 Oct;191(2):194-206. doi: 10.1111/bjh.17027. Epub 2020 Aug 12. Br J Haematol. 2020. PMID: 32678948 Free PMC article.
• Hyperuricemia in leukemia and lymphoma. I. Clinical findings and pathophysiology.

  Pochedly C. Pochedly C. N Y State J Med. 1973 May 1;73(9):1085-92. N Y State J Med. 1973. PMID: 4572306 Review. No abstract available.